Global Drug-Induced Cardiotoxicity Market Analysis By Type (Chemotherapy-Induced Cardiotoxicity, Antipsychotic Drug-Induced Cardiotoxicity), By Detection (Biomarkers, Imaging Techniques), By Drug Class (Tyrosine Kinase Inhibitors (TKIs), Antibiotics, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: June 2024
- Report ID: 73803
- Number of Pages: 295
- Format:
                                        
- 
                                            keyboard_arrow_up
- 
                                            
- 
                                            - Novartis AG Company Profile
- Pfizer Inc Company Profile
- Siemens Healthineers
- GE Healthcare
- Amgen Inc
- Bristol Myers Squibb Company Profile
- Mayo Clinic
- Cleveland Clinic
 
Our Clients
✖
        Request a Sample Report
        We'll get back to you as quickly as possible
        
     
                    
 
            


